The pharmaceuticals and healthcare sector in Indonesia is at an early stage of development although sectoral maturity has been growing in recent years. Industry development has been catalysed, to some degree, by the rollout of the Indonesian government’s JKN programme that promises universal healthcare to all Indonesians by 2019. This has significantly increased healthcare demand as more patients become able to afford healthcare, and the higher demand has motivated the growth in supply of healthcare services as well as medical devices and pharmaceuticals. In many cases in the medical devices and pharmaceuticals subsectors, products are imported but the Indonesian government has been seeking to increase the share of local production to reduce import dependence.

01 EXECUTIVE SUMMARY 

02 SECTOR IN FOCUS 

03 COMPETITIVE LANDSCAPE 

04 COMPANIES IN FOCUS

05 REGULATORY ENVIRONMENT 

06 HEALTHCARE SERVICES 

07 MEDICAL DEVICES 

08 PHARMACEUTICALS 

09 RETAIL CHANNELS